Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05600192
Other study ID # PI19/00507
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 18, 2021
Est. completion date December 31, 2023

Study information

Verified date September 2022
Source Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Exercise could be an element that affects the biochemical, metabolic and microbiome parameters of organisms. Thus, to identify and validate the effects of aerobic and anaerobic exercises at different times of the day (morning or afternoon) on mitochondrial fitness and whether this changes could have a relation with metabolism and cardiovascular parameters and microbiome is of great interest for its applicability in biomedicine. As specific objectives of this project will study: 1. - To study the direct effect of aerobic and anaerobic exercise at different time points in the day on mitochondria fitness (short study: basal, at the end of the exercise and 2 h after exercise). 2. - To study mitochondria fitness under morning or afternoon aerobic and anaerobic exercise (prospective study: basal, 4, 8 and 12 weeks of the study). 3. - To identify and validate modulators and target proteins of mitochondria fitness affected by exercise (miRNA omic and proteomic analysis of mitochondria from the different groups of the study at basal and 12 weeks of the study). 4. - To study the relationship of the mitochondrial response (Objectives 1 and 2) to the different combination of exercises and chronobiology with anthropometric-clinical, carbohydrate and lipid metabolic and cardiovascular changes. 5. - To check the effect of morning or afternoon aerobic and anaerobic exercise on gut microbiota and its relation to mitochondria fitness, clinical and metabolic parameters (basal, 4, 8 and 12 weeks of the study).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date December 31, 2023
Est. primary completion date July 29, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 55 Years
Eligibility Inclusion Criteria: - 20- - IMC <30 kg/m2 - Informed consent Exclusion Criteria: - Smoker - Previous physical exercise of more than 20 minutes / 2 times a week

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Aerobic or anaerobic exercise
Aerobic or anaerobic exercise in the morning or in the afternoon

Locations

Country Name City State
Spain Hospital Universitario Virgen de la Victoria Málaga

Sponsors (1)

Lead Sponsor Collaborator
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in weight Weight in kg From baseline to week 12
Primary BMI (body mass index) changes Measured by body composition analysis From baseline to week 12
Primary Change in waist circumference Circumference in cm From baseline to week 12
Primary Change in hip circumference Circumference in cm From baseline to week 12
Primary Changes in diastolic and systolic blood pressure To analyze the effect of exercise on blood pressure From baseline to week 12
Primary Changes in body composition To analyze the effect of exercise on anthropometric parameters measured by bioelectrical impedance analysis From baseline to week 12
Primary Change in glucose concentration Glucose in mg/dl From baseline to week 12
Primary Change in insulin concentration Insulin in mg/dl From baseline to week 12
Primary Change in glycated haemoglobin concentration Glycated haemoglobin in mg/dl From baseline to week 12
Primary Change in Triglycerides concentration Triglycerides in mg/dl From baseline to week 12
Primary Change in cholesterol concentration Serum cholesterol in mg/dl From baseline to week 12
Primary Change in HDL concentration Serum HDL in mg/dl From baseline to week 12
Primary Change in LDL concentration Serum LDL in mg/dl From baseline to week 12
Primary Change in transaminases concentration Serum transaminases in UI/l From baseline to week 12
Primary Change in creatinine concentration Creatinine in mg/dl From baseline to week 12
Primary Change in uric acid concentration Uric acid in mg/dl From baseline to week 12
Primary Change in alkaline phosphatase concentration Serum alkaline phosphatase in UI/l From baseline to week 12
Primary Change in bilirubin concentration Serum bilirubin in mg/dl From baseline to week 12
Primary Change in lactate concentration Serum lactate in mmol/L From baseline to week 12
Primary Change in cortisol concentration Serum cortisol in nmol/L From baseline to week 12
Primary Change in total and free testosterone concentration Serum total and free testosterone in nmol/L From baseline to week 12
Primary Change in melatonine concentration Serum melatonine in pg/ml From baseline to week 12
Primary Characterize exercise participant behavior International Physical Activity Questionnaire (IPAQ). The IPAQ consists of 7 questions about the frequency, duration and intensity of activity (moderate and intense) carried out in the last seven days, as well as walking and sitting time in a work day. It evaluates three characteristics of physics (PA): intensity (mild, moderate or vigorous), frequency (days per week) and duration (time per day). Weekly activity is recorded in Mets (Metabolic Equivalent of Task or Metabolic Index Units) per minute and week. From baseline to week 12
Primary Mediterranean diet adherence questionnaire To evaluate adherence to a Mediterranean diet pattern. It consists of 14 items in which different components of the Mediterranean diet are evaluated (number of pieces of fruit consumed per day, number of portions of legumes consumed per week...). Each item is scored as 0 or 1. A total score of <9 indicates poor adherence, while a score of =9 indicates good adherence. From baseline to week 12
Primary Change in faecal microbiota To evaluate faecal microbiota composition in the studied subjects and the effect of aerobic and anaerobic exercise in the morning or afternoon on faecal microbiota composition. 16S rRNA amplicons of fecal community DNA From baseline to week 12
Primary Change in fitness mitochondrial To evaluate the effect of aerobic and anaerobic exercise in the morning or afternoon on mitochondrial fitness, evaluated by mitochondrial gene expression and protein abundance, mitochondrial metabolites, mitochondrial markers trough flow citometry. From baseline to week 12
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1